Top Stocks with Expert Buy Recommendations in June 2025
In the past trading week, numerous experts have highlighted various stocks as attractive buy recommendations for private investors, savers, and small investors. These recommendations are based on current market analyses and growth potentials of the companies.
Uber Technologies (WKN: A2PHHG)
Uber is recommended as a top investment by several experts. The company is a market leader in ridesharing and delivery services, two rapidly growing markets with high scaling potential. In the first quarter of 2025, Uber achieved adjusted revenue growth of 17% to $11.5 billion, along with a free cash flow of $2.3 billion. Despite risks such as autonomous driving or consolidation pressure, Uber is considered to be undervalued with an enterprise value of around $189 billion. The stock is currently showing a clear upward movement.
Nike (NKE)
Nike is among the recommended stocks for June 2025 due to its strong brand position and stable revenues worldwide.
Pfizer (PFE)
The pharmaceutical company Pfizer is also frequently mentioned, attributed to its solid pipeline of drugs and vaccines.
Other recommended companies include:
- Campbell Soup Company (CPB)
- Yum China Holdings (YUMC)
- Thermo Fisher Scientific (TMO)
- Brown-Forman Corporation (BF.B)
These companies are characterized by stable business models in their respective industries.
Further Recommendations from Analyst Circles
In addition to the mentioned stocks, finance professionals also recommend:
- Deutsche Bank: JPMorgan still considers Deutsche Bank attractive with a target price of about €26.30 and rates it as “Overweight”.
- thyssenkrupp nucera: There is also a buy recommendation with a target price of around €12 from Deutsche Bank Research.
Conclusion
For private investors, stocks like Uber Technologies, Nike, and Pfizer are currently particularly appealing—all companies with solid fundamentals and growth prospects in their markets. Additionally, stocks like Deutsche Bank or thyssenkrupp nucera may also be interesting, depending on risk profiles.
These recommendations reflect the assessments of experienced analysts and could provide valuable guidance for investment decisions in June 2025.